Global pioneers of convenient treatment for allergy and immune related disorders.
Transforming lives by delivering convience.
As a Healthcare professional, you understand the importance of convenience in allergy treatments, because this allows you to deliver the best patient care.
We are a visionary immunology business with specialist experience in the research and development of allergy treatments.
Work with us.
Intralymphatic immunotherapy with a grass allergen microcrystalline tyrosine adsorbate resulted in reduced medication use and symptoms in patients with allergic rhinoconjunctivitis: a double-blind randomized placebo-controlled trial
Early inflammatory reactions in mice after immunotherapy with an allergen microcrystalline tyrosine adsorbate
Microcrystalline Tyrosine and Monophosphoryl Lipid A: an adjuvant system which aids the immunogenic effect of SCIT.
TAPAS - a long-term non-interventional study evaluating MCT (MicroCrystalline Tyrosine)-associated allergoids shows non-inferiority of clinical effectiveness in children compared to adults during a 3-year course of allergen immunotherapy
Analyzing factors influencing adherence to classify adherence levels in patients treated with allergen immunotherapy
